Dr Taas Naka Worley King, DO | |
710 Birchwood Ave, Suite 201, Bellingham, WA 98225-1720 | |
(360) 788-6870 | |
(360) 788-6872 |
Full Name | Dr Taas Naka Worley King |
---|---|
Gender | Female |
Speciality | Neurology |
Experience | 17 Years |
Location | 710 Birchwood Ave, Bellingham, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417154113 | NPI | - | NPPES |
1417154113 | Medicaid | MI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 5101017375 (Michigan) | Secondary |
2084N0400X | Psychiatry & Neurology - Neurology | OP60463152 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Joseph Hospital | Bellingham, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peacehealth | 9537073960 | 259 |
News Archive
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the February 1, 2014 print edition of the International Journal of Radiation Oncology.
A Sheffield Hallam University study has found that obese men and women are less likely to be employed because of their weight.
Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP Specific IgE blood test, the market leading in vitro allergy diagnostic test.
› Verified 7 days ago
Entity Name | Peacehealth |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the February 1, 2014 print edition of the International Journal of Radiation Oncology.
A Sheffield Hallam University study has found that obese men and women are less likely to be employed because of their weight.
Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP Specific IgE blood test, the market leading in vitro allergy diagnostic test.
› Verified 7 days ago
Entity Name | Peacehealth Peace Island Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508129842 PECOS PAC ID: 9335391044 Enrollment ID: O20130122000273 |
News Archive
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the February 1, 2014 print edition of the International Journal of Radiation Oncology.
A Sheffield Hallam University study has found that obese men and women are less likely to be employed because of their weight.
Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP Specific IgE blood test, the market leading in vitro allergy diagnostic test.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Taas Naka Worley King, DO 1115 Se 164th Ave, Dept 358, Vancouver, WA 98683-9324 Ph: (360) 788-6870 | Dr Taas Naka Worley King, DO 710 Birchwood Ave, Suite 201, Bellingham, WA 98225-1720 Ph: (360) 788-6870 |
News Archive
Ruthigen, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, today announced that the Company has submitted an Investigational New Drug (IND) Application to the U.S. Food and Drug Administration for its lead drug candidate RUT58-60.
Long-term outcomes of breast cancer patients receiving adjuvant accelerated partial breast irradiation after breast-conserving surgery show excellent tumor control and breast cosmesis (cosmetic outcomes) with minimal late toxicity, according to a study published in the February 1, 2014 print edition of the International Journal of Radiation Oncology.
A Sheffield Hallam University study has found that obese men and women are less likely to be employed because of their weight.
Phadia, the worldwide leader of in vitro allergy diagnostics, is pleased to contribute to the largest cross-sectional allergy study ever conducted through the use of its ImmunoCAP Specific IgE blood test, the market leading in vitro allergy diagnostic test.
› Verified 7 days ago
Mr. Ronald A Remick, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 609 N Shore Dr, Bellingham, WA 98226 Phone: 360-676-6000 Fax: 360-676-6006 | |
Dr. Neelam Kumari Sampley, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1133 Railroad Ave Ste 100, Bellingham, WA 98225 Phone: 916-835-0144 | |
Zachary Alan Webb, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1345 King St, Bellingham, WA 98229 Phone: 360-676-1696 Fax: 360-676-6636 | |
Ario H Hosseini, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1050 Larrabee Ave Ste 104-510, Bellingham, WA 98225 Phone: 360-200-8962 | |
Dr. Andrew Denzil Pauli, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1116 Key St Ste 200, Bellingham, WA 98225 Phone: 360-671-1369 Fax: 360-671-0981 | |
Danielle L Kizer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2901 Squalicum Pkwy, Attn:behavioral Health Services, Bellingham, WA 98225 Phone: 360-788-6993 Fax: 360-715-6996 | |
Dr. James M Harle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1112 11th Street, 301, Bellingham, WA 98225 Phone: 360-414-2222 Fax: 360-414-2220 |